Total Shoulder Arthroplasty Multi-Center Registry
1 other identifier
observational
2,500
3 countries
24
Brief Summary
The objective of the study is a multi-center prospective registry to collect clinical outcomes of anatomic and reverse total shoulder arthroplasty.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jul 2015
Longer than P75 for all trials
24 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 28, 2015
CompletedFirst Submitted
Initial submission to the registry
April 12, 2018
CompletedFirst Posted
Study publicly available on registry
April 30, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2035
ExpectedStudy Completion
Last participant's last visit for all outcomes
November 1, 2035
August 11, 2025
June 1, 2025
19.9 years
April 12, 2018
August 6, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Change in Pain
Measure of pain intensity. This is done with the Visual Analog Scare. (VAS)
10 years
Eligibility Criteria
All adult patients who are seeking treatment or are undergoing a shoulder replacement procedure utilizing an Arthrex shoulder arthroplasty prostheses are being invited to participate in this research registry.
You may qualify if:
- Patient voluntarily consents to participate in the study and has the mental and physical ability to participate in the study, fill out subjective questionnaires, return for follow-up visits, and comply with prescribed post-operative physical therapy.
- Patient is between the ages of 18 and 100 years.
- The patient has a planned primary or revision implantation of an anatomic (hemi-arthroplasty or total arthroplasty) or a reverse shoulder prosthesis system manufactured by Arthrex.
- Patient has a standard of care preoperative CT taken within 6 months that has been submitted for Arthrex VIP (Virtual Implant Positioning) planning.
You may not qualify if:
- \. Patient has known intentions, obligations, or co-morbidity that would inhibit them from participating in the study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Arthrex, Inc.lead
Study Sites (24)
University of Arizona/Banner Health
Phoenix, Arizona, 85006, United States
Banner Medical Group
Phoenix, Arizona, 85016, United States
Unknown Facility
Scottsdale, Arizona, United States
Unknown Facility
Denver, Colorado, United States
University of Connecticut Health Center
Farmington, Connecticut, 06030, United States
Andrews Research & Education Foundation
Gulf Breeze, Florida, 32561, United States
Advent Health Orlando
Orlando, Florida, United States
NorthShore University Health System
Evanston, Illinois, 60201, United States
The Trustees of Indiana University
Indianapolis, Indiana, 46202, United States
The University of Michigan
Ann Arbor, Michigan, 48105, United States
Unknown Facility
Grand Rapids, Michigan, United States
Unknown Facility
Columbia, Missouri, United States
The Rothman Institute
New York, New York, 10022, United States
University of North Carolina
Chapel Hill, North Carolina, 27599, United States
Wake Forest University Health Sciences
Winston-Salem, North Carolina, 27157, United States
Cleveland Shoulder Institute
Beachwood, Ohio, 44122, United States
Unknown Facility
Medford, Oregon, United States
Rothman Orthopaedic Institute
Philadelphia, Pennsylvania, United States
The Hawkins Foundation
Greenville, South Carolina, 29615, United States
Unknown Facility
Germantown, Tennessee, United States
University of Virginia
Charlottesville, Virginia, 22903, United States
Unknown Facility
Virginia Beach, Virginia, United States
Orthopädische Chirurgie München (OCM)
München, 81369, Germany
Schulthess Klinik
Zurich, 8008, Switzerland
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 10 Years
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 12, 2018
First Posted
April 30, 2018
Study Start
July 28, 2015
Primary Completion (Estimated)
July 1, 2035
Study Completion (Estimated)
November 1, 2035
Last Updated
August 11, 2025
Record last verified: 2025-06
Data Sharing
- IPD Sharing
- Will not share